Adherex Technologies (FENC) Competitors $8.71 -0.08 (-0.91%) Closing price 04:00 PM EasternExtended Trading$8.72 +0.01 (+0.11%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FENC vs. NRIX, PRAX, AKBA, SYRE, MLYS, SION, AVXL, ORIC, LENZ, and ZYMEShould you be buying Adherex Technologies stock or one of its competitors? The main competitors of Adherex Technologies include Nurix Therapeutics (NRIX), Praxis Precision Medicines (PRAX), Akebia Therapeutics (AKBA), Spyre Therapeutics (SYRE), Mineralys Therapeutics (MLYS), Sionna Therapeutics (SION), Anavex Life Sciences (AVXL), Oric Pharmaceuticals (ORIC), LENZ Therapeutics (LENZ), and Zymeworks (ZYME). These companies are all part of the "pharmaceutical products" industry. Adherex Technologies vs. Its Competitors Nurix Therapeutics Praxis Precision Medicines Akebia Therapeutics Spyre Therapeutics Mineralys Therapeutics Sionna Therapeutics Anavex Life Sciences Oric Pharmaceuticals LENZ Therapeutics Zymeworks Adherex Technologies (NASDAQ:FENC) and Nurix Therapeutics (NASDAQ:NRIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has more volatility and risk, FENC or NRIX? Adherex Technologies has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Nurix Therapeutics has a beta of 2.15, indicating that its stock price is 115% more volatile than the S&P 500. Do institutionals and insiders hold more shares of FENC or NRIX? 55.5% of Adherex Technologies shares are held by institutional investors. 11.0% of Adherex Technologies shares are held by company insiders. Comparatively, 7.4% of Nurix Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is FENC or NRIX more profitable? Adherex Technologies has a net margin of -45.52% compared to Nurix Therapeutics' net margin of -234.57%. Adherex Technologies' return on equity of 0.00% beat Nurix Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Adherex Technologies-45.52% N/A -26.37% Nurix Therapeutics -234.57%-45.26%-34.71% Does the media favor FENC or NRIX? In the previous week, Nurix Therapeutics had 24 more articles in the media than Adherex Technologies. MarketBeat recorded 28 mentions for Nurix Therapeutics and 4 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 1.18 beat Nurix Therapeutics' score of 0.32 indicating that Adherex Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nurix Therapeutics 5 Very Positive mention(s) 2 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts recommend FENC or NRIX? Adherex Technologies presently has a consensus target price of $13.00, suggesting a potential upside of 49.25%. Nurix Therapeutics has a consensus target price of $29.31, suggesting a potential upside of 141.26%. Given Nurix Therapeutics' higher possible upside, analysts clearly believe Nurix Therapeutics is more favorable than Adherex Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Nurix Therapeutics 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.82 Which has preferable valuation & earnings, FENC or NRIX? Adherex Technologies has higher earnings, but lower revenue than Nurix Therapeutics. Adherex Technologies is trading at a lower price-to-earnings ratio than Nurix Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$47.54M5.06-$440K-$0.51-17.08Nurix Therapeutics$54.55M17.03-$193.57M-$2.61-4.66 SummaryAdherex Technologies beats Nurix Therapeutics on 10 of the 17 factors compared between the two stocks. Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FENC vs. The Competition Export to ExcelMetricAdherex TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.60M$2.96B$5.62B$9.30BDividend YieldN/A2.43%4.25%4.03%P/E Ratio-17.0820.2228.5719.58Price / Sales5.06293.85424.2194.37Price / Cash272.1743.1536.0257.93Price / Book-41.487.568.135.54Net Income-$440K-$55.11M$3.24B$257.73M7 Day Performance0.11%7.56%2.03%0.95%1 Month Performance9.84%11.47%8.29%10.68%1 Year Performance33.18%0.88%28.40%15.67% Adherex Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FENCAdherex Technologies2.1706 of 5 stars$8.71-0.9%$13.00+49.3%+37.6%$242.60M$47.54M-17.0810News CoveragePositive NewsAnalyst UpgradeNRIXNurix Therapeutics2.4347 of 5 stars$12.36-2.9%$30.18+144.1%-46.7%$970.48M$54.55M-4.41300Earnings ReportAnalyst ForecastAnalyst RevisionPRAXPraxis Precision Medicines2.2492 of 5 stars$46.68-1.2%$92.11+97.3%+5.3%$962.64M$8.55M-4.35110AKBAAkebia Therapeutics3.6514 of 5 stars$3.63+0.3%$6.75+86.0%+215.1%$950.74M$160.18M-17.28430SYRESpyre Therapeutics1.9928 of 5 stars$15.30-2.9%$53.40+249.0%-44.7%$949.94M$890K-4.0673Positive NewsGap UpMLYSMineralys Therapeutics2.1547 of 5 stars$13.53-6.9%$32.25+138.4%+3.7%$947.65MN/A-3.6328News CoverageInsider TradeSIONSionna TherapeuticsN/A$20.96-1.1%$38.50+83.7%N/A$935MN/A0.0035Positive NewsAVXLAnavex Life Sciences3.9273 of 5 stars$9.99-7.4%$44.00+340.4%+113.0%$921.16MN/A-18.1640News CoverageORICOric Pharmaceuticals4.5538 of 5 stars$10.65-1.4%$19.17+80.0%+7.9%$920.42MN/A-5.7080LENZLENZ Therapeutics1.3305 of 5 stars$31.48-3.2%$46.60+48.0%+60.4%$915.59MN/A-17.79110News CoverageAnalyst RevisionZYMEZymeworks3.039 of 5 stars$13.08+0.3%$21.00+60.6%+32.6%$910.07M$93.38M-8.72460 Related Companies and Tools Related Companies Nurix Therapeutics Alternatives Praxis Precision Medicines Alternatives Akebia Therapeutics Alternatives Spyre Therapeutics Alternatives Mineralys Therapeutics Alternatives Sionna Therapeutics Alternatives Anavex Life Sciences Alternatives Oric Pharmaceuticals Alternatives LENZ Therapeutics Alternatives Zymeworks Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FENC) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FENC Stock Alerts